Guideline of guidelines: prostate cancer screening.

Guideline of guidelines: prostate cancer screening.

Item
http://www.wikidata.org/entity/Q38224949
Prostate-specific antigen reduction after empiric antibiotic treatment does not rule out biopsy in patients with lower urinary tract symptoms: prospective, controlled, single-center study.Prostate-specific antigen-based screening: controversy and guidelinesDevelopment of a voided urine assay for detecting prostate cancer non-invasively: a pilot study.What's new in screening in 2015?VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man.How Men with Prostate Cancer Choose Specialists: A Qualitative Study.Clinical Consultation Guide: How to Optimize the Use of Prostate-specific Antigen in the Current Era.Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.Metastatic prostate cancer initially presenting as chylothorax: A case report.Who and when should we screen for prostate cancer? Interviews with key opinion leaders.Spotlight on prostate cancer: the latest evidence and current controversies.Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.Prostate cancer screening-when to start and how to screen?
P2860

Guideline of guidelines: prostate cancer screening.

Item
http://www.wikidata.org/entity/Q38224949
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Guideline of guidelines: prostate cancer screening.
@en
type
label
Guideline of guidelines: prostate cancer screening.
@en
prefLabel
Guideline of guidelines: prostate cancer screening.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Guideline of guidelines: prostate cancer screening
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698